Crossref
EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION
Value in Health · 2026-06 · 29 (6) · S128
DOI: 10.1016/j.jval.2026.03.635 ↗Kurz gefasst
Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Yosr Ziadi und 1 weiteren Autor:innen.
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ziadi, Y., & Park, T. (2026). EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION. Value in Health, 29(6), S128. https://doi.org/10.1016/j.jval.2026.03.635
Vancouver
Ziadi Y, Park T. EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION. Value in Health. 2026;29(6):S128. doi:10.1016/j.jval.2026.03.635
BibTeX
@article{Ziadi2026,
author = {Ziadi, Yosr and Park, Taehwan},
title = {EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION},
journal = {Value in Health},
year = {2026},
volume = {29},
number = {6},
pages = {S128},
doi = {10.1016/j.jval.2026.03.635}
}
EUVIMED